A Prospective Observational Cohort Study of Indwelling Pleural Catheters Versus Indwelling Pleural Catheters Plus Doxycycline Pleurodesis for Treatment of Malignant Pleural Effusions

Status: Recruiting
Location: See location...
Intervention Type: Drug, Other, Procedure, Device
Study Type: Observational
SUMMARY

This study is designed to obtain preliminary data comparing indwelling pleural catheters (IPCs) versus IPCs plus doxycycline for pleurodesis as treatments for malignant pleural effusion (MPE). Indwelling pleural catheters (IPCs) are commonly used to treat pleural effusions (build-up of fluid in the lungs). Doxycycline is an antibiotic that is also used to treat pleural effusions. The goal of this clinical research study is to learn if adding doxycycline to the use of an IPC can lead to shorter treatment times with IPCs.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Outpatients with MPE undergoing IPC placement

• Sufficient mental capacity to provide informed consent and answer Short-Form Six-Dimension health index (SF-6D) and Borg score questions

• Inpatients that are expected to be discharged within 5 days of receiving an indwelling pleural catheter

Locations
United States
Texas
M D Anderson Cancer Center
RECRUITING
Houston
Contact Information
Primary
David Ost
dost@mdanderson.org
713-792-6238
Time Frame
Start Date: 2018-03-08
Estimated Completion Date: 2025-04-30
Participants
Target number of participants: 208
Treatments
Group 2 (IPC alone)
Patients undergo IPC placement.
Group I (IPC, doxycycline)
Patients undergo IPC placement and receive doxycycline via IPC 5 days later.
Authors
Related Therapeutic Areas
Sponsors
Leads: M.D. Anderson Cancer Center
Collaborators: National Cancer Institute (NCI)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials